Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals.
biologics
chaperones
cleavage
folding
glycosylation
proteases
Journal
Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
10
01
2020
revised:
06
03
2020
accepted:
06
03
2020
entrez:
21
8
2020
pubmed:
21
8
2020
medline:
20
7
2021
Statut:
ppublish
Résumé
Production of biologics in plants, or plant molecular pharming, is a promising protein expression technology that is receiving increasing attention from the pharmaceutical industry. Previously, low expression yields of recombinant proteins and the realization that certain post-translational modifications (PTMs) may not occur optimally limited the widespread acceptance of the technology. However, molecular engineering of the plant secretory pathway is now enabling the production of increasingly complex biomolecules using tailored protein-specific approaches to ensure their maturation. These involve the elimination of undesired processing events, and the introduction of heterologous biosynthetic machinery to support the production of specific target proteins. Here, we discuss recent advances in the production of pharmaceutical proteins in plants, which leverage the unique advantages of the technology.
Identifiants
pubmed: 32818443
pii: S0167-7799(20)30064-0
doi: 10.1016/j.tibtech.2020.03.004
pii:
doi:
Substances chimiques
Plant Proteins
0
Recombinant Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1034-1044Subventions
Organisme : Austrian Science Fund FWF
ID : P 31920
Pays : Austria
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.